Results 71 to 80 of about 120,543 (256)

Incarceration history and opioid use among adults living with HIV and chronic pain: a secondary analysis of a prospective cohort study

Health & Justice
Background Adults living with HIV have disproportionately high chronic pain, prescription opioid use, history of substance use, and incarceration. While incarceration can have long-lasting health impacts, prior studies have not examined whether distant (>
Anna B. Lichtiger, Yuting Deng, Chenshu Zhang, Justina Groeger, Hector R. Perez, Gayatri Nangia, Melanie Prinz, Emma Richard, Matthew Glenn, Ana Alicia De La Cruz, Ariana Pazmino, Chinazo O. Cunningham, K Rivet Amico, Aaron Fox, Joanna L. Starrels   +14 more
doaj   +1 more source

Dopamine D3 Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats. [PDF]

, 2019
Prescription opioids, such as oxycodone, are highly effective analgesics for clinical pain management, but approximately 25% of patients who are prescribed opioids misuse them, and 5%-10% develop an opioid use disorder (OUD).
de Guglielmo, Giordano, George, Olivier, Kallupi, Marsida, Newman, Amy H, Sedighim, Sharona   +4 more
core  

Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown

Addiction Science & Clinical Practice, 2022
Background Morbidity and mortality related to opioid use disorder (OUD) in the U.S. is at an all-time high. Innovative approaches are needed to address gaps in retention in treatment with medications for opioid use disorder (MOUD). Mobile health (mHealth)
Jacqueline Hodges, Marika Waselewski, William Harrington, Taylor Franklin, Kelly Schorling, Jacqueline Huynh, Alexa Tabackman, Kori Otero, Karen Ingersoll, Nassima Ait-Daoud Tiouririne, Tabor Flickinger, Rebecca Dillingham   +11 more
doaj   +1 more source

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV

Drug and Alcohol Dependence Reports, 2023
Background: In the United States, a disproportionate number of persons with HIV (PWH) and opioid use disorder (OUD) are involved in the justice system. Medications for OUD (MOUD) can reduce convictions and incarceration time in persons with OUD. Extended-
Kaley Parchinski, Angela Di Paola, Allison P. Wilson, Sandra A. Springer   +3 more
doaj  

Putting Families First: How the Opioid Epidemic is Affecting Children and Families, and the Child Welfare Policy Options to Address It [PDF]

, 2019
: Opioids and Child Welfare Across the country, placements in foster care are rising. In 2016, the U.S. Department of Health and Human Services reported that 273,539 children in the U.S. entered foster care.
American Academy of Pediatrics Council on Foster Care, Adoption, and Kinship Care, Greiner, Mary V, Laris, Zach, Waite, Douglas   +3 more
core   +1 more source

Consensus recommendations on the treatment of opioid use disorder in the emergency department [PDF]

, 2021
The treatment of opioid use disorder with buprenorphine and methadone reduces morbidity and mortality in patients with opioid use disorder. The initiation of buprenorphine in the emergency department (ED) has been associated with increased rates of ...
D\u27Onofrio, Gail, Hawk, Kathryn, Hoppe, Jason, Ketcham, Eric, LaPietra, Alexis, Moulin, Aimee, Nelson, Lewis, Schwarz, Evan, Shahid, Sam, Stader, Donald, Wilson, Michael P   +10 more
core   +1 more source

Administration of Long-Acting Injections [PDF]

, 2018
Expanding the scope of pharmacy practice demonstrates that the profession has been successful at improving public health. Despite being a late adopter, New York\u27s limited experience with vaccines has improved immunization rates and lowered rates of ...
Noel, Christopher, Williams, Karl
core   +1 more source

Editorial: Opioids and opioid-use disorders

Frontiers in Pharmacology, 2023
Giordano de Guglielmo, Marsida Kallupi, Andrea Cippitelli, Daniele Caprioli, Daniele Caprioli, Kabirullah Lutfy   +5 more
openaire   +4 more sources

The Individualized Treatment of Opioid Use Disorder [PDF]

Journal of Managed Care & Specialty Pharmacy, 2019
No outside funding supported the writing of this commentary. Boyett is Chief Medical Officer and founder of the medical division of Pathway Healthcare, which provides treatment for opioid and other drug addictions.
openaire   +2 more sources

Innovations in Opioid Law and Policy Interventions Workshop: Summary of Proceedings [PDF]

, 2018
In 2017, Indiana University, in cooperation with Indiana Governor Eric Holcomb and community partners, launched the Grand Challenge: Responding to the Addictions Crisis initiative, a university-wide effort to advance interdisciplinary research and ...
Beukema, Emily, Hoss, Aila, Silverman, Ross D., Terry, Nicolas P.   +3 more
core